Instituto De Investigación Biomédica De Salamanca
Clinical trials sponsored by Instituto De Investigación Biomédica De Salamanca, explained in plain language.
-
Scientists test new 'Living Drug' to fight aggressive lymphoma
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy called TranspoCART19 for adults with B-cell lymphoma that has come back or hasn't responded to standard treatments. Doctors will modify a patient's own immune cells to better target and fight their cancer, then infuse …
Phase: PHASE1, PHASE2 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Surgery safety boost? new study tests 90% less dye to map bile ducts
Diagnosis Recruiting nowThis study aims to make a common gallbladder surgery safer by improving how surgeons see the bile ducts. It will compare two different doses of a safe, fluorescent dye that lights up the ducts during surgery. The goal is to see if a much smaller, more convenient dose works just a…
Phase: PHASE4 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Diagnosis
Last updated Mar 30, 2026 14:27 UTC
-
Scientists hunt for clues to make skin cancer treatment more personal
Knowledge-focused Recruiting nowThis study aims to find biological markers in the blood and tumor that can predict how patients with advanced skin cancer (cutaneous squamous cell carcinoma) will respond to the immunotherapy drug cemiplimab. Researchers will enroll about 30 patients starting this treatment and u…
Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Scientists track long COVID patients for four years to unlock mystery of lingering symptoms
Knowledge-focused Recruiting nowThis study aims to understand why Long COVID symptoms like severe fatigue last for years in some people. Researchers will re-check 400 people from a previous study four years later, measuring their symptoms, blood vessel health, and blood markers. The goal is to find patterns tha…
Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC